Showing results (271-280 of 332) with videos related to
Sort By:
Pageof 34
Neurology|July 1, 2021
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple SclerosisIzanne Roos, Emmanuelle Leray, Romain Casey, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 4, 2021
Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like SyndromeGuillaume Taieb, Elsa Kaphan, Claire Duflos, et al.Neurology|January 8, 2017
Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodiesLe-Duy Do, Eve Chanson, Virginie Desestret, et al.Journal of Neurology|January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.Journal of Neurology|February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.Seminars in Arthritis and Rheumatism|April 11, 2017
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patientsYvan Jamilloux, Fleur Cohen-Aubart, Catherine Chapelon-Abric, et al.Neurology|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024Thomas Roux, François-Xavier Lejeune, Romain Casey, et al.Journal of Neuroinflammation|July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated diseaseAlvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.Genes and Immunity|March 20, 2026
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patientsSara Benavides, Scott Christley, Kiel M Telesford, et al.Archives of Neurology|October 10, 2007
Acute fulminant demyelinating disease: a descriptive study of 60 patientsJérôme de Seze, Marc Debouverie, Hélène Zephir, et al.Pageof 34